State Of Wyoming Burning Rock Biotech LTD Transaction History

State Of Wyoming

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$2.15 - $3.16 $189 - $278	88 Added 43.56%	290 $0
Q1 2023 May 12, 2023	SELL	$2.16 - $3.47 $19 - $31	-9 Reduced 4.27%	202 $0
Q4 2022 Feb 14, 2023	BUY	$1.73 - $2.95 $256 - $436	148 Added 234.92%	211 $0
Q3 2022 Nov 14, 2022	BUY	$2.39 - $3.96 $150 - $249	63 New	63 $0
Q2 2022 Aug 15, 2022	SELL	$1.75 - $10.44 $22 - $135	-13 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$6.7 - $10.23 $13 - $20	2 Added 18.18%	13 $0
Q4 2021 Feb 11, 2022	SELL	$9.43 - $17.14 $9 - $17	-1 Reduced 8.33%	11 $0
Q3 2021 Feb 11, 2022	SELL	$17.37 - $27.92 $104 - $167	-6 Reduced 33.33%	12 $0
Q2 2021 Feb 11, 2022	BUY	$26.14 - $37.45 $261 - $374	10 Added 125.0%	18 $1,000
Q1 2021 Feb 08, 2022	BUY	$23.5 - $39.58 $188 - $316	8 New	8 $0

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $716M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.